SCHEMBL254114

SCHEMBL254114

C=CCC1CCCCO1.[AlH3]

nearest known ligand 0.33

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.33
HPGD P15428 2/20 0.32
HTT P42858 1/20 0.32
NOS1 P29475 4/20 0.32
NOS2 P35228 4/20 0.32
NOS3 P29474 2/20 0.32
PDE8B O95263 2/20 0.31
LMNA P02545 1/20 0.31
POLB P06746 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TSHR P16473 1/20 0.31
USP2 O75604 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3346237 0.98
SCHEMBL127017 0.91
SCHEMBL28643681 0.89
SCHEMBL2106921 0.84
Ethylene Glycol SCHEMBL6419138 0.83 LMNA (0.36) KMT2AHPGDHTTLMNAPOLB
Methoxymethane SCHEMBL28422588 0.83 LMNA (0.36) KMT2AHPGDPDE8BLMNAPOLB
SCHEMBL26744022 0.77 HPGD (0.33) KMT2AHPGDHTTLMNAPOLB
SCHEMBL10391665 0.76
SCHEMBL1961412 0.76
SCHEMBL28359152 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1819744-B1 RANDOM COPOLYMERS AND FORMULATIONS USEFUL FOR THERMOFORMING AND BLOW MOLDING APPLICATIONS TOTAL RES & TECHNOLOGY FELUY (BE) 2015-09-30 EP claimed
EP-1694723-B1 PREPARATION OF OLEFIN-ACRYLIC COPOLYMERS WITH LATE TRANSITION METAL CATALYSTS EQUISTAR CHEM LP (US) 2007-05-02 EP claimed
US-20060127348-A1 Chemically and/or biologically reactive compounds ISOTRON CORPORATION (US) 2006-06-15 US claimed
WO-2003092656-A1 CHEMICALLY AND/OR BIOLOGICALLY REACTIVE COMPOUDS ISOTRON CORPORATION (US) 2003-11-13 WO claimed
US-20030055148-A1 Process for preparation of polyolefin/inorganic component nanocomposite by in-situ polymerization CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY CHINESE ACADEMY OF SCIENCE (CN) 2003-03-20 US claimed
EP-0226463-B2 Polymerization catalyst EXXON CHEMICAL PATENTS INC (US) 1994-09-07 EP claimed
EP-0244678-B1 PROCESS FOR PRODUCING ALPHA-OLEFIN POLYMER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1990-07-04 EP claimed
EP-0196585-B1 CATALYST AND PROCESS FOR PRODUCING ALPHA-OLEFIN POLYMERS USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1989-09-20 EP claimed
EP-1777239-B1 Half-metallocene catalyst and process for preparing syndiotactic styrene polymer using the same LG CHEMICAL LTD (KR) 2014-09-10 EP disclosed
CN-103930203-A Process for the oxidation of hydrocarbons with the use of iridium metal catalyst complexes UNIV RUTGERS 2014-07-16 CN disclosed
EP-2047061-B1 A COMPOSITION AND METHOD FOR MAKING A PROPPANT OXANE MATERIALS INC (US) 2014-03-05 EP disclosed
US-8603578-B2 Composition and method for making a proppant OXANE MATERIALS, INC. (US) 2013-12-10 US disclosed
US-20130022816-A1 Composition And Method For Making A Proppant OXANE MATERIALS, INC. (US) 2013-01-24 US disclosed
US-8298667-B2 Composition and method for making a proppant Oxane Materials (US) 2012-10-30 US disclosed
US-5698487-A Components and catalysts for the polymerization of olefins MONTELL TECHNOLOGY COMPANY BV (NL) 1997-12-16 US disclosed
WO-1997032906-A1 STABLE METALLOCENE CATALYST SYSTEMS EXXON CHEMICAL PATENTS INC. (US) 1997-09-12 WO disclosed
EP-0739365-A1 ALUMOXANES AND CATALYSTS COMPRISING ALUMOXANES EXXON CHEMICAL PATENTS INC. (US) 1996-10-30 EP disclosed
EP-0712416-A1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS Montell Technology Company bv (NL) 1996-05-22 EP disclosed
WO-1995032995-A1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS MONTELL TECHNOLOGY COMPANY BV (NL) 1995-12-07 WO disclosed
WO-1995018836-A1 ALUMOXANES AND CATALYSTS COMPRISING ALUMOXANES EXXON CHEMICAL PATENTS INC. (US) 1995-07-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060127348-A1 Chemically and/or biologically reactive compounds VIM, CD44, EPCAM KMT2A 2882/4885HPGD 2982/4885HTT 1729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.